Vandetanib (CAS 443913-73-3)
« Back to Anti-Cancer API
Vandetanib
CAS No. 443913-73-3
凡德他尼
Chemical structure
| CAS No. | 443913-73-3 |
|---|---|
| Synonyms | 4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline |
| Category | Anti-Cancer API / Anti-Cancer |
| Assay / Purity | 99% |
| Molecular Formula | C22H24BrFN4O2 |
| Molecular Weight | 475.4 |
| Melting Point | — |
| Boiling Point | — |
| Density | — |
| Flash Point | — |
| Appearance | Off-white to white solid powder |
Application and positioning
Vandetanib is an inhibitor of the VEGFR2, EGFR and RET tyrosine kinases. It is used in oral tablets for unresectable or metastatic medullary thyroid cancer. Laurand supplies it from audited Chinese production partners for pharmaceutical manufacturing and process development.
Quality and documentation
- Batch-specific Certificate of Analysis issued by the manufacturing site
- SDS/MSDS and specification sheet available on request
- Residual solvents and elemental impurities statements discussed per project
- For pharmaceutical manufacturing and R&D use only — not for direct administration
Packaging and handling
- Packed in double polyethylene-lined fibre drums; pack size confirmed at quotation
- Small quantities in sealed aluminium foil bags
- Palletised for air and sea freight; store dry, ventilated and protected from light
Related products
- Veliparib dihydrochloride (CAS 912445-05-7)
- Vemurafenib (CAS 918504-65-1)
- Abemaciclib, LY2835219 (CAS 1231929-97-7)
- Acalabrutinib, ACP-196 (CAS 1420477-60-6)
Specifications shown are indicative. The final specification and documentation package are confirmed with the quotation.
Interested in this product?
Contact us for price, COA, MSDS and lead time — custom synthesis available.
Request a QuoteReference: CAS 443913-73-3 · PubChem CID 3081361